Black Diamond Therapeutics Inc logo

BDTX - Black Diamond Therapeutics Inc News Story

$25.86 0.6  2.5%

Last Trade - 16/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £675.7m
Enterprise Value £447.9m
Revenue £n/a
Position in Universe 2891st / 6850

BRIEF-Black Diamond Therapeutics Inc Announces Quarterly Loss Per Share $0.50

Tue 10th November, 2020 1:09pm
Nov 10 (Reuters) - Black Diamond Therapeutics Inc  BDTX.O :
    * QTRLY LOSS PER SHARE $0.50
    * BLACK DIAMOND THERAPEUTICS-CASH,CASH EQUIVALENTS,
INVESTMENTS OF
$333.1 MILLION AS OF SEPT 30, 2020 EXPECTED TO BE SUFFICIENT TO
FUND OPERATIONS INTO 2023
    * Q3 EARNINGS PER SHARE VIEW $-0.52 -- REFINITIV IBES DATA

Source: [ID: https://bit.ly/3eIKrsq]
Further company coverage:  BDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.